Wells Fargo’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.81M | Sell |
94,762
-34,208
| -27% | -$756K | ﹤0.01% | 3347 |
|
|
2025
Q4 | $3.12M | Buy |
128,970
+16,086
| +14% | +$421K | ﹤0.01% | 3083 |
|
|
2025
Q3 | $2.88M | Buy |
112,884
+327
| +0.3% | +$7.76K | ﹤0.01% | 3050 |
|
|
2025
Q2 | $2.42M | Buy |
112,557
+8,445
| +8% | +$190K | ﹤0.01% | 3079 |
|
|
2025
Q1 | $2.38M | Sell |
104,112
-381
| -0.4% | -$10K | ﹤0.01% | 3032 |
|
|
2024
Q4 | $2.71M | Buy |
104,493
+5,322
| +5% | +$132K | ﹤0.01% | 2956 |
|
|
2024
Q3 | $2.48M | Sell |
99,171
-5,114
| -5% | -$121K | ﹤0.01% | 2882 |
|
|
2024
Q2 | $2.23M | Buy |
104,285
+35,824
| +52% | +$695K | ﹤0.01% | 2895 |
|
|
2024
Q1 | $1.27M | Buy |
68,461
+59,282
| +646% | +$1.04M | ﹤0.01% | 3291 |
|
|
2023
Q4 | $149K | Buy |
9,179
+2,077
| +29% | +$26.5K | ﹤0.01% | 4646 |
|
|
2023
Q3 | $98.1K | Sell |
7,102
-9,332
| -57% | -$147K | ﹤0.01% | 4792 |
|
|
2023
Q2 | $363K | Buy |
16,434
+8,439
| +106% | +$178K | ﹤0.01% | 4177 |
|
|
2023
Q1 | $174K | Buy |
7,995
+6,898
| +629% | +$155K | ﹤0.01% | 4520 |
|
|
2022
Q4 | $20K | Sell |
1,097
-1,166
| -52% | -$24.1K | ﹤0.01% | 5262 |
|
|
2022
Q3 | $52K | Sell |
2,263
-1,922
| -46% | -$41.1K | ﹤0.01% | 4934 |
|
|
2022
Q2 | $57K | Sell |
4,185
-4,240
| -50% | -$62.2K | ﹤0.01% | 4960 |
|
|
2022
Q1 | $192K | Sell |
8,425
-5,463
| -39% | -$144K | ﹤0.01% | 5002 |
|
|
2021
Q4 | $517K | Sell |
13,888
-3,090
| -18% | -$133K | ﹤0.01% | 4646 |
|
|
2021
Q3 | $719K | Sell |
16,978
-304
| -2% | -$14.6K | ﹤0.01% | 4452 |
|
|
2021
Q2 | $768K | Sell |
17,282
-209
| -1% | -$7.36K | ﹤0.01% | 4380 |
|
|
2021
Q1 | $629K | Sell |
17,491
-27,783
| -61% | -$1.1M | ﹤0.01% | 4565 |
|
|
2020
Q4 | $1.81M | Sell |
45,274
-32,446
| -42% | -$1.11M | ﹤0.01% | 3570 |
|
|
2020
Q3 | $2.25M | Buy |
77,720
+8,483
| +12% | +$183K | ﹤0.01% | 3216 |
|
|
2020
Q2 | $1.13M | Buy |
69,237
+189
| +0.3% | +$2.61K | ﹤0.01% | 3714 |
|
|
2020
Q1 | $656K | Buy |
69,048
+4,949
| +8% | +$68K | ﹤0.01% | 3825 |
|
|
2019
Q4 | $1.04M | Buy |
64,099
+1,996
| +3% | +$32.5K | ﹤0.01% | 3839 |
|
|
2019
Q3 | $1.03M | Sell |
62,103
-23,024
| -27% | -$432K | ﹤0.01% | 3816 |
|
|
2019
Q2 | $1.44M | Sell |
85,127
-8,019
| -9% | -$140K | ﹤0.01% | 3612 |
|
|
2019
Q1 | $1.67M | Buy |
93,146
+3,784
| +4% | +$60.2K | ﹤0.01% | 3504 |
|
|
2018
Q4 | $1.07M | Buy |
89,362
+13,893
| +18% | +$166K | ﹤0.01% | 3789 |
|
|
2018
Q3 | $1.32M | Buy |
75,469
+1
| +0% | +$20 | ﹤0.01% | 3749 |
|
|
2018
Q2 | $861K | Buy |
75,468
+73,968
| +4,931% | +$673K | ﹤0.01% | 4100 |
|
|
2018
Q1 | $8K | Sell |
1,500
-17,013
| -92% | -$92.1K | ﹤0.01% | 5981 |
|
|
2017
Q4 | $111K | Buy |
+18,513
| New | +$107K | ﹤0.01% | 5260 |
|
|
2017
Q1 | – | Sell |
-22
| Closed | – | – | 6305 |
|
|
2016
Q4 | $0 | Buy |
+22
| New | +$36 | ﹤0.01% | 6254 |
|
Other funds holding BLFS
CC
VCM
FAM
Wells Fargo's BLFS Position: Q1 2026 in Review
Wells Fargo reduced its BioLife Solutions (BLFS) stake by 27% in Q1 2026, selling an estimated $756K and leaving 94,762 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #3347.
Wells Fargo first reported a position in BLFS in Q4 2016 and has held it in 35 quarters since. The position peaked at $3.12M in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.
- Wells Fargo held 94,762 shares of BioLife Solutions worth $1.81M as of Q1 2026.
- Wells Fargo sold 34,208 BioLife Solutions shares in Q1 2026, an estimated $756K.
- BioLife Solutions made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3347 holding.
- Wells Fargo first reported a position in BioLife Solutions in Q4 2016 and has held it in 35 quarters since.
- Wells Fargo's BioLife Solutions position peaked at $3.12M in Q4 2025.
- 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.